Zobrazeno 1 - 10
of 282
pro vyhledávání: '"Harry Hollema"'
Autor:
Jorien M. Woolderink, Geertruida H. De Bock, Bettien M. van Hemel, Erwin Geuken, Harry Hollema, Naomi Werner, Marian J. Mourits
Publikováno v:
BMC Women's Health, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background Endometrial sampling for the surveillance of women with Lynch syndrome is an invasive and painful procedure. The aim of this study was to evaluate the feasibility of a less invasive procedure of collecting vital cells by vaginal t
Externí odkaz:
https://doaj.org/article/18d8ed0e1c984c4c991e1268970ce207
Autor:
Fenne L. Komdeur, Thalina M. Prins, Stephanie van de Wall, Annechien Plat, G. Bea A. Wisman, Harry Hollema, Toos Daemen, David N. Church, Marco de Bruyn, Hans W. Nijman
Publikováno v:
OncoImmunology, Vol 6, Iss 9 (2017)
Human papilloma virus (HPV)-induced cervical cancer constitutively expresses viral E6/E7 oncoproteins and is an excellent target for T cell-based immunotherapy. However, not all tumor-infiltrating T cells confer equal benefit to patients, with epithe
Externí odkaz:
https://doaj.org/article/8c326f638d40436ea9c6619326bca178
Autor:
Nan Yang, Esther R. Nijhuis, Haukeline H. Volders, Jasper J. H. Eijsink, Ágnes Lendvai, Bo Zhang, Harry Hollema, Ed Schuuring, G. Bea A. Wisman, Ate G. J. van der Zeea
Publikováno v:
Cellular Oncology, Vol 32, Iss 1-2, Pp 131-143 (2010)
Objectives: To determine methylation status of nine genes, previously described to be frequently methylated in cervical cancer, in squamous intraepithelial lesions (SIL).
Externí odkaz:
https://doaj.org/article/e09faa22ca994a188cd5d5d7fc3b4714
Autor:
Esther R. Nijhuis, Nathalie Reesink-Peters, G. Bea A. Wisman, Hans W. Nijman, Jelmer van Zanden, Haukeline Volders, Harry Hollema, Albert J. H. Suurmeijer, Ed Schuuring, Ate G. J. van der Zee
Publikováno v:
Cellular Oncology, Vol 28, Iss 5-6, Pp 233-246 (2006)
Although current cytomorphology-based cervical cancer screening has reduced the incidence of cervical cancer, Papsmears are associated with high false positive and false negative rates. This has spurred the search for new technologies to improve curr
Externí odkaz:
https://doaj.org/article/e3eb6cdd104b439eaa046df6e0b957d5
Autor:
Renee Vermeij, Toos Daemen, Geertruida H. de Bock, Pauline de Graeff, Ninke Leffers, Annechien Lambeck, Klaske A. ten Hoor, Harry Hollema, Ate G. J. van der Zee, Hans W. Nijman
Publikováno v:
Clinical and Developmental Immunology, Vol 2010 (2010)
The prognosis of epithelial ovarian cancer (EOC), the primary cause of death from gynaecological malignancies, has only modestly improved over the last decades. Immunotherapeutic treatment using a cocktail of antigens has been proposed as a “univer
Externí odkaz:
https://doaj.org/article/3a3d1eab845a458bb2b9a343d0185062
Autor:
Anne P G Crijns, Rudolf S N Fehrmann, Steven de Jong, Frans Gerbens, Gert Jan Meersma, Harry G Klip, Harry Hollema, Robert M W Hofstra, Gerard J te Meerman, Elisabeth G E de Vries, Ate G J van der Zee
Publikováno v:
PLoS Medicine, Vol 6, Iss 2, p e24 (2009)
BackgroundOvarian cancer has a poor prognosis due to advanced stage at presentation and either intrinsic or acquired resistance to classic cytotoxic drugs such as platinum and taxoids. Recent large clinical trials with different combinations and sequ
Externí odkaz:
https://doaj.org/article/b4910f46b04e47b29451059654179ad5
Autor:
Tjalling Bosse, Brooke E. Howitt, Vincent T.H.B.M. Smit, Flora E. van Leeuwen, Christi J. van Asperen, Matti A. Rookus, Harry Hollema, Rutika Puranik, Jeremy P. Segal, Maaike P.G. Vreeswijk, Cornelis D. de Kroon, Lauren L. Ritterhouse, Marthe M. de Jonge
Class 4/5 mutations and Tumor Mutational Burden stratified by loss of heterozygosity status.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b6554e3d74b2a412bff760bc43f3ef6
https://doi.org/10.1158/1078-0432.22471688.v1
https://doi.org/10.1158/1078-0432.22471688.v1
Autor:
Hans W. Nijman, Marco de Bruyn, Toos Daemen, Evelien W. Duiker, Harry Hollema, Cornelis J.M. Melief, Steven de Jong, Refika Yigit, Maaike H.M. Oonk, Henriette J.G. Arts, Marian J.E. Mourits, G. Bea A. Wisman, Neeltje M. Kooi, Annechien Plat, Harry G. Klip, Hagma H. Workel, Fenne L. Komdeur, Maartje C.A. Wouters
Disease-specific survival (DSS) analyses by Kaplan Meier method of the primary surgery (PS) cohort for high and low infiltration of CD27+ cells. CD27 infiltration in the tumor epithelium is a prognostic factor in patients in which the surgical cytore
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fde066cdbfecdcdba60f4e54783d38d
https://doi.org/10.1158/1078-0432.22461353.v1
https://doi.org/10.1158/1078-0432.22461353.v1
Autor:
Tjalling Bosse, Brooke E. Howitt, Vincent T.H.B.M. Smit, Flora E. van Leeuwen, Christi J. van Asperen, Matti A. Rookus, Harry Hollema, Rutika Puranik, Jeremy P. Segal, Maaike P.G. Vreeswijk, Cornelis D. de Kroon, Lauren L. Ritterhouse, Marthe M. de Jonge
Germline BRCA1/2 Mutations and Variant Allele Frequencies detected in the FFPE-isolated tumor DNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::655b5ef24d6d98e1df3215e63f754e88
https://doi.org/10.1158/1078-0432.22471679.v1
https://doi.org/10.1158/1078-0432.22471679.v1
Autor:
Tjalling Bosse, Brooke E. Howitt, Vincent T.H.B.M. Smit, Flora E. van Leeuwen, Christi J. van Asperen, Matti A. Rookus, Harry Hollema, Rutika Puranik, Jeremy P. Segal, Maaike P.G. Vreeswijk, Cornelis D. de Kroon, Lauren L. Ritterhouse, Marthe M. de Jonge
Purpose:Whether endometrial carcinoma (EC) should be considered part of the gBRCA1/2-associated hereditary breast and ovarian cancer (HBOC) syndrome is topic of debate. We sought to assess whether ECs occurring in gBRCA carriers are enriched for clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2abbf9306faf63e830bdd8b26ecb3cd7
https://doi.org/10.1158/1078-0432.c.6527963.v1
https://doi.org/10.1158/1078-0432.c.6527963.v1